The integration of molecular biomarkers into their classification has transformed the field, particularly through the distinction between grade 4 adult-type diffuse gliomas: IDH-wildtype (IDH-wt) glioblastoma and IDH-mutant (IDH-mut) astrocytoma [1]. The gene discussed is IDH1; the disease is glioblastoma.